Next Article in Journal
Inherently Chiral Calixarenes: Synthesis, Optical Resolution, Chiral Recognition and Asymmetric Catalysis
Next Article in Special Issue
Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo
Previous Article in Journal
Study of OH Radicals in Human Serum Blood of Healthy Individuals and Those with Pathological Schizophrenia
Previous Article in Special Issue
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Article Menu

Export Article

Open AccessReview
Int. J. Mol. Sci. 2011, 12(1), 410-428;

Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery

Adelaide Proteomics Centre, School of Molecular and Biomedical Science, University of Adelaide, Adelaide, Australia
Research Centre for Reproductive Health, School of Paediatrics and Reproductive Health, Robinson Institute, University of Adelaide, Adelaide, Australia
Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide, Australia
Author to whom correspondence should be addressed.
Received: 30 November 2010 / Accepted: 12 January 2011 / Published: 14 January 2011
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer)
Full-Text   |   PDF [1380 KB, uploaded 19 June 2014]


Most scientific efforts towards early detection of ovarian cancer are commonly focused on the discovery of tumour-associated antigens (TAA). Autologous antibodies against TAA, however, may serve as more sensitive diagnostic markers. They circulate in the blood before TAA and are usually more abundant than the TAAs themselves as a result of amplification through the humoral immune response. Accumulating evidence also suggests that a humoral response already exists during malignant transformation when aberrant gene expression is translated into premalignant cellular changes. This article reviews the current knowledge about autoantibodies against TAA in ovarian cancer and presents current immunoproteomic approaches for their detection. View Full-Text
Keywords: ovarian cancer; autoantibodies; immunoproteomics ovarian cancer; autoantibodies; immunoproteomics
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Martin, K.; Ricciardelli, C.; Hoffmann, P.; Oehler, M.K. Exploring the Immunoproteome for Ovarian Cancer Biomarker Discovery. Int. J. Mol. Sci. 2011, 12, 410-428.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top